Zuid-Afrika - Engels - South African Health Products Regulatory Authority (SAHPRA)

accord healthcare (pty) ltd - powder - 50,0 mg - each vial contains decitabine 50,0 mg

Verenigde Staten - Engels - NLM (National Library of Medicine)

abbvie inc. - venetoclax (unii: n54aic43pw) (venetoclax - unii:n54aic43pw) - venetoclax 10 mg - venclexta is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll). venclexta is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (aml) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. concomitant use of venclexta with strong cyp3a inhibitors at initiation and during the ramp-up phase is contraindicated in patients with cll/sll due to the potential for increased risk of tumor lysis syndrome [see dosage and administration ( 2.6 ) and drug interactions ( 7.1 )] . risk summary based on findings in animals and its mechanism of action [see clinical pharmacology ( 12.1 )] , venclexta may cause embryo-fetal harm when administered to a pregnant woman. there are no available data on venclexta use in pregnant women to inform a drug-associated risk. administration of venetoclax to pregnant mice during

Bahrein - Engels - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - decitabine - iv solution - 50

Filipijnen - Engels - FDA (Food And Drug Administration)

n/a; importer: johnson & johnson (phils.), inc.; distributor: zuellig pharma corporation - decitabine - powder for injection (iv infusion) - 50mg

Filipijnen - Engels - FDA (Food And Drug Administration)

sun pharma philippines, inc.; distributor: sun pharma philippines, inc. - decitabine - lyophilized powder for injection (i.v.) - 50mg

Filipijnen - Engels - FDA (Food And Drug Administration)

apolloplus capital inc.; distributor: apolloplus capital inc. - decitabine - lyophilized powder for infusion (iv) - 50 mg

Filipijnen - Engels - FDA (Food And Drug Administration)

one source pharma solutions, inc.; distributor: one source pharma solutions, inc. - decitabine - lyophilized powder for injection iv infusion - 50mg

Filipijnen - Engels - FDA (Food And Drug Administration)

n/a; importer: sun pharma philippines, inc.; distributor: sun pharma philippines, inc. - decitabine - lyophilized powder for injection (i.v.) - 50 mg

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharma pharmaceutical industries (ppi), saudi arabia - decitabine - powder for solution for infusion - 50 mg,

Filipijnen - Engels - FDA (Food And Drug Administration)

n/a; importer: accord healthcare limited - philippine branch office; distributor: accord healthcare limited - philippine branch office - decitabine - lyophilized powder for infusion (iv) - 50mg